StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 21 Jul 2026 20:49:07 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Picard Medical announces 1-for-50 reverse stock split http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html <p>Picard Medical, Inc. (NYSE American: PMI) announced that its board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding common stock, following stockholder approval at the company's annual meeting held July 17, 2026.</p> <p>The reverse stock split is set to take effect at 5:00 p.m. Eastern Time on July 31, 2026. The company's common stock is expected to begin trading on a split-adjusted basis on August 3, 2026, under the existing ticker symbol "PMI" with a new CUSIP number of 71953R 207.</p> <p>Stockholders had authorized a reverse stock split ratio in the range of 1-for-15 to http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html Tue, 21 Jul 2026 20:49:07 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical announces 1-for-50 reverse stock split http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html <p>Picard Medical, Inc. (NYSE American: PMI) announced that its board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding common stock, following stockholder approval at the company's annual meeting held July 17, 2026.</p> <p>The reverse stock split is set to take effect at 5:00 p.m. Eastern Time on July 31, 2026. The company's common stock is expected to begin trading on a split-adjusted basis on August 3, 2026, under the existing ticker symbol "PMI" with a new CUSIP number of 71953R 207.</p> <p>Stockholders had authorized a reverse stock split ratio in the range of 1-for-15 to http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html Tue, 21 Jul 2026 20:49:07 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical announces 1-for-50 reverse stock split http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html <p>Picard Medical, Inc. (NYSE American: PMI) announced that its board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding common stock, following stockholder approval at the company's annual meeting held July 17, 2026.</p> <p>The reverse stock split is set to take effect at 5:00 p.m. Eastern Time on July 31, 2026. The company's common stock is expected to begin trading on a split-adjusted basis on August 3, 2026, under the existing ticker symbol "PMI" with a new CUSIP number of 71953R 207.</p> <p>Stockholders had authorized a reverse stock split ratio in the range of 1-for-15 to http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html Tue, 21 Jul 2026 20:49:07 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical announces 1-for-50 reverse stock split http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html <p>Picard Medical, Inc. (NYSE American: PMI) announced that its board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding common stock, following stockholder approval at the company's annual meeting held July 17, 2026.</p> <p>The reverse stock split is set to take effect at 5:00 p.m. Eastern Time on July 31, 2026. The company's common stock is expected to begin trading on a split-adjusted basis on August 3, 2026, under the existing ticker symbol "PMI" with a new CUSIP number of 71953R 207.</p> <p>Stockholders had authorized a reverse stock split ratio in the range of 1-for-15 to http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html Tue, 21 Jul 2026 20:49:07 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical announces 1-for-50 reverse stock split http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html <p>Picard Medical, Inc. (NYSE American: PMI) announced that its board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding common stock, following stockholder approval at the company's annual meeting held July 17, 2026.</p> <p>The reverse stock split is set to take effect at 5:00 p.m. Eastern Time on July 31, 2026. The company's common stock is expected to begin trading on a split-adjusted basis on August 3, 2026, under the existing ticker symbol "PMI" with a new CUSIP number of 71953R 207.</p> <p>Stockholders had authorized a reverse stock split ratio in the range of 1-for-15 to http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html Tue, 21 Jul 2026 20:49:07 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical announces 1-for-50 reverse stock split http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html <p>Picard Medical, Inc. (NYSE American: PMI) announced that its board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding common stock, following stockholder approval at the company's annual meeting held July 17, 2026.</p> <p>The reverse stock split is set to take effect at 5:00 p.m. Eastern Time on July 31, 2026. The company's common stock is expected to begin trading on a split-adjusted basis on August 3, 2026, under the existing ticker symbol "PMI" with a new CUSIP number of 71953R 207.</p> <p>Stockholders had authorized a reverse stock split ratio in the range of 1-for-15 to http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html Tue, 21 Jul 2026 20:49:07 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical announces 1-for-50 reverse stock split http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html <p>Picard Medical, Inc. (NYSE American: PMI) announced that its board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding common stock, following stockholder approval at the company's annual meeting held July 17, 2026.</p> <p>The reverse stock split is set to take effect at 5:00 p.m. Eastern Time on July 31, 2026. The company's common stock is expected to begin trading on a split-adjusted basis on August 3, 2026, under the existing ticker symbol "PMI" with a new CUSIP number of 71953R 207.</p> <p>Stockholders had authorized a reverse stock split ratio in the range of 1-for-15 to http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html Tue, 21 Jul 2026 20:49:07 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical announces 1-for-50 reverse stock split http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html <p>Picard Medical, Inc. (NYSE American: PMI) announced that its board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding common stock, following stockholder approval at the company's annual meeting held July 17, 2026.</p> <p>The reverse stock split is set to take effect at 5:00 p.m. Eastern Time on July 31, 2026. The company's common stock is expected to begin trading on a split-adjusted basis on August 3, 2026, under the existing ticker symbol "PMI" with a new CUSIP number of 71953R 207.</p> <p>Stockholders had authorized a reverse stock split ratio in the range of 1-for-15 to http://www.streetinsider.com/Stock+Splits/Picard+Medical+announces+1-for-50+reverse+stock+split/26796861.html Tue, 21 Jul 2026 20:49:07 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Press+Releases/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html <p align="center"><em>-Reverse stock split to support continued compliance with NYSE American continued listing standards-</em></p> <p>TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current http://www.streetinsider.com/Globe+Newswire/Picard+Medical+Announces+Reverse+Stock+Split+Following+Stockholder+Approval+to+Support+Continued+NYSE+American+Listing+Compliance/26796859.html Tue, 21 Jul 2026 20:48:00 -0400 A.06822034 A.17150087 A.50204203 O.20026344 O.21447847 O.34929518 O.71638566 PMI Form 8-K Picard Medical, Inc. For: Jul 17 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Picard+Medical%2C+Inc.++++++For%3A+Jul+17/26795017.html si-local-file:///var/storage/secattach/20260721/26795017.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Picard+Medical%2C+Inc.++++++For%3A+Jul+17/26795017.html Tue, 21 Jul 2026 14:02:00 -0400 O.21447847 PMI